Infraredx last week officially withdrew the planned initial public offering it hoped would raise $56 million, citing “unfavorable market conditions.”
Burlington, Mass.-based Infraredx makes an imaging system that combines intravascular ultrasound and near-infrared spectroscopy to provide images of the interior of coronary blood vessels. The company says the device is designed to detect lipid-core-containing plaque, which it says is implicated in higher risk for heart attack or stroke.
Help employers find you! Check out all the jobs and post your resume.
